Exact Mass: 446.164177
Exact Mass Matches: 446.164177
Found 500 metabolites which its exact mass value is equals to given mass value 446.164177,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Thioproperazine
C22H30N4O2S2 (446.18100799999996)
Thioproperazine is a potent neuroleptic with antipsychotic properties. Thioproperazine has a marked cataleptic and antiapomorphine activity associated with relatively slight sedative, hypothermic and spasmolytic effects. It is virtually without antiserotonin and hypotensive action and has no antihistaminic property. It is used for the treatment of all types of acute and chronic schizophrenia, including those which did not respond to the usual neuroleptics; manic syndromes. Overdosage may result in severe extrapyramidal symptoms with dysphagia, marked sialorrhea, persistent and rapidly increasing hyperthermia, pulmonary syndrome, state of shock with pallor and profuse sweating, which may be followed by collapse and coma. LD50 in mice is 70 mg/kg I.V., 120 mg/kg I.P., 500 mg/kg S.C. and 830 mg/kg P.O. N - Nervous system > N05 - Psycholeptics > N05A - Antipsychotics > N05AB - Phenothiazines with piperazine structure C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent Thioproperazine (RP 7843) is an orally active antipsychotic agent with calming, antiemetic activity. Thioproperazine is effective in promoting the release of dopamine in rat striatum. Thioproperazine can be used in studies of schizophrenia and bipolar disorder[1].
Osmanthuside A
Osmanthuside C is found in herbs and spices. Osmanthuside C is isolated from Osmanthus fragrans (sweet osmanthus). Isolated from Osmanthus fragrans (sweet osmanthus). Osmanthuside C is found in herbs and spices.
Gefitinib
C22H24ClFN4O3 (446.15208759999996)
Gefitinib (originally coded ZD1839) is a drug used in the treatment of certain types of cancer. Acting in a similar manner to erlotinib (marketed as Tarceva), gefitinib selectively targets the mutant proteins in malignant cells. It is marketed by AstraZeneca under the trade name Iressa. [Wikipedia] L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors > L01EB - Epidermal growth factor receptor (egfr) tyrosine kinase inhibitors C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163952 - EGFR-targeting Agent C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors D000970 - Antineoplastic Agents
Crosatoside B
Crosatoside B is isolated from the pollen of Crocus sativus (saffron). Isolated from the pollen of Crocus sativus (saffron)
(S)-4-ethyl-4-hexanoyloxy-1,12-dihydro-4H-pyrano[3,4:6,7]indolizino[1,2-b]quinoline-3,14-dione|20-Hexanoyl-camptothecin|4(S)-ethyl-4-hexanoyl-1H-pyrano-[3,4:6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione|O-hexanoyl-camptothecin
C26H26N2O5 (446.18416260000004)
2H-1-Benzopyran-3,4-diol, 2-(3,4-dimethoxyphenyl)-3,4-dihydro-7,8-dimethoxy-, diacetate, [2R-(2.alpha.,3.alpha.,4.alpha.)]-
(2S,4R)-7,4-dihydroxy-6,8-dimethyl-4,2-oxidoflavan-5-O-beta-D-glucopyranoside|abacopterin F
9alpha,13alpha-dihydroxyisopropylidenylisatisine A
phenethyl alcohol 8-O-beta-D-glucopyranosyl-(1->2)-beta-D-glucopyranoside|phenethyl alcohol 8-O-beta-D-glucopyranosyl-(1->2)-O-beta-D-glucopyranoside|phenethyl alcohol beta-D-(2-O-beta-D-glucopyranosyl)glucopyranoside|phenethyl beta-D-sophoroside|phenethyl O-beta-D-glucopyranosyl-(1->2)-beta-D-glucopyranoside|Phenethylalcohol 8-O-??-D-glucopyranosyl-(1鈥樏傗垎2)-??-D-glucopyranoside|phenylethyl-O-beta-D-glucopyranosyl-(1->2)-beta-D-glucopyranoside
4-methoxybenzyl-O-alpha-L-rhamnopyranosyl (1->6)-beta-D-glucopyranoside
4-methoxy-2,5-dimethylphenyl alpha-L-arabinofuranosyl-(1->6)-beta-D-glucopyranoside|illoliganoside A
nepodin-8-O-beta-D-(60-O-trans-crotonoyl)glucopyranoside|rumexneposide A
7-O-beta-glucopyranosyl demethoxymatteucinol|demethoxymatteucinol-7-O-beta-D-glucopyranoside|demethoxymatteuocinol 7-O-glucopyranoside
5,6,6-Trimethoxy-4,10-dihydroxy-11,12-dimethyl-4,5-(epoxymethanoxy)-2,2-butanobiphenyl-3-carboxylic acid
7-beta-D-glucopyranosyloxymethyl-9-methoxy-5H-dibenzo[a,c][7]annulene-3,10-diol|subavenoside C
(1S)-1-(2-hydroxy-6-methylphenyl)ethanol 2-O-(6-O-alpha-L-arabinofuranosyl)-beta-D-glucopyranoside|juniperoside VII
4-hydroxyphenylethyl 4-O-beta-D-glucopyranosyl-(1->3)-O-alpha-L-rhamnopyranoside|strigoside
beta-hydroxy-phenylethyl-O-alpha-L-rhamnopyranosyl (1->6)-beta-D-glucopyranoside
2-phenylethyl 6-O-(beta-D-glucopyranosyl)-beta-D-glucopyranoside|2-phenylethyl 6-O-beta-D-glucopyranosyl-beta-D-glucopyranoside|2-phenylethyl beta-gentiobioside|phenethyl alcohol beta-D-glucopyranosyl(1- >6)-beta-D-O-glucopyranoside|phenethyl alcohol beta-D-glucopyranosyl-(1->6)-beta-D-glucopyranoside|phenethyl alcohol beta-gentiobioside
(-)-15-methoxypodorhizol|(-)-5-methoxypodorhizol|5-Methoxypodorhizol
(1R,2R)-1-(3-methoxy-4,5-methylenedioxyphenyl)-2-methyl-3-oxobutyl 3,4,5-trimethoxybenzoate|tsangin B
O-beta-D-Galactopyranosyl-(1->4)-O-beta-D-galactopyranosyl-(1->2)-L-erythritol
(1S,2R)-2-methyl-3-oxo-1-(3,4,5-trimethoxyphenyl)butyl 3-methoxy-4,5-methylenedioxybenzoate|tsangin A
2-[2-(4-Methyl-2-oxo-2H-chromen-7-yloxy)-acetyl]-1,2,3,4-tetrahydro-beta-carbolin-3-ylcarboxylic acid methyl ester
C20H30O11_2-(4-Methoxyphenyl)ethyl 6-O-alpha-L-arabinopyranosyl-beta-D-glucopyranoside
C20H30O11_2-Phenylethyl 2-O-beta-D-glucopyranosyl-beta-D-glucopyranoside
(2R,3R,4S,5S,6R)-2-[2-(4-methoxyphenyl)ethoxy]-6-[[(2S,3R,4S,5S)-3,4,5-trihydroxyoxan-2-yl]oxymethyl]oxane-3,4,5-triol
Thioproperazine
C22H30N4O2S2 (446.18100799999996)
N - Nervous system > N05 - Psycholeptics > N05A - Antipsychotics > N05AB - Phenothiazines with piperazine structure C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent Thioproperazine (RP 7843) is an orally active antipsychotic agent with calming, antiemetic activity. Thioproperazine is effective in promoting the release of dopamine in rat striatum. Thioproperazine can be used in studies of schizophrenia and bipolar disorder[1].
(2R,3R,4S,5S,6R)-2-[2-(4-methoxyphenyl)ethoxy]-6-[[(2S,3R,4S,5S)-3,4,5-trihydroxyoxan-2-yl]oxymethyl]oxane-3,4,5-triol_major
Ala Asp Asn Gln
Ala Asp Gln Asn
Ala Glu Met Pro
Ala Glu Asn Asn
Ala Glu Pro Met
Ala Met Glu Pro
Ala Met Pro Glu
Ala Asn Asp Gln
Ala Asn Glu Asn
Ala Asn Asn Glu
Ala Asn Gln Asp
Ala Pro Glu Met
Ala Pro Met Glu
Ala Gln Asp Asn
Ala Gln Asn Asp
Cys Asp Ile Pro
Cys Asp Leu Pro
Cys Asp Pro Ile
Cys Asp Pro Leu
Cys Glu Pro Val
Cys Glu Val Pro
Cys His Ser Thr
C16H26N6O7S (446.15836060000004)
Cys His Thr Ser
C16H26N6O7S (446.15836060000004)
Cys Ile Asp Pro
Cys Ile Pro Asp
Cys Leu Asp Pro
Cys Leu Pro Asp
Cys Met Pro Pro
Cys Asn Asn Pro
C16H26N6O7S (446.15836060000004)
Cys Asn Pro Asn
C16H26N6O7S (446.15836060000004)
Cys Pro Asp Ile
Cys Pro Asp Leu
Cys Pro Glu Val
Cys Pro Ile Asp
Cys Pro Leu Asp
Cys Pro Met Pro
Cys Pro Asn Asn
C16H26N6O7S (446.15836060000004)
Cys Pro Pro Met
Cys Pro Val Glu
Cys Ser His Thr
C16H26N6O7S (446.15836060000004)
Cys Ser Thr His
C16H26N6O7S (446.15836060000004)
Cys Thr His Ser
C16H26N6O7S (446.15836060000004)
Cys Thr Ser His
C16H26N6O7S (446.15836060000004)
Cys Val Glu Pro
Cys Val Pro Glu
Asp Ala Asn Gln
Asp Ala Gln Asn
Asp Cys Ile Pro
Asp Cys Leu Pro
Asp Cys Pro Ile
Asp Cys Pro Leu
Asp Asp Pro Thr
C17H26N4O10 (446.16488560000005)
Asp Asp Thr Pro
C17H26N4O10 (446.16488560000005)
Asp Glu Pro Ser
C17H26N4O10 (446.16488560000005)
Asp Glu Ser Pro
C17H26N4O10 (446.16488560000005)
Asp Gly Gln Gln
Asp Ile Cys Pro
Asp Ile Pro Cys
Asp Leu Cys Pro
Asp Leu Pro Cys
Asp Asn Ala Gln
Asp Asn Gln Ala
Asp Pro Cys Ile
Asp Pro Cys Leu
Asp Pro Asp Thr
C17H26N4O10 (446.16488560000005)
Asp Pro Glu Ser
C17H26N4O10 (446.16488560000005)
Asp Pro Ile Cys
Asp Pro Leu Cys
Asp Pro Ser Glu
C17H26N4O10 (446.16488560000005)
Asp Pro Thr Asp
C17H26N4O10 (446.16488560000005)
Asp Gln Ala Asn
Asp Gln Gly Gln
Asp Gln Asn Ala
Asp Gln Gln Gly
Asp Ser Glu Pro
C17H26N4O10 (446.16488560000005)
Asp Ser Pro Glu
C17H26N4O10 (446.16488560000005)
Asp Thr Asp Pro
C17H26N4O10 (446.16488560000005)
Asp Thr Pro Asp
C17H26N4O10 (446.16488560000005)
Glu Ala Met Pro
Glu Ala Asn Asn
Glu Ala Pro Met
Glu Cys Pro Val
Glu Cys Val Pro
Glu Asp Pro Ser
C17H26N4O10 (446.16488560000005)
Glu Asp Ser Pro
C17H26N4O10 (446.16488560000005)
Glu Gly Asn Gln
Glu Gly Gln Asn
Glu Met Ala Pro
Glu Met Pro Ala
Glu Asn Ala Asn
Glu Asn Gly Gln
Glu Asn Asn Ala
Glu Asn Gln Gly
Glu Pro Ala Met
Glu Pro Cys Val
Glu Pro Asp Ser
C17H26N4O10 (446.16488560000005)
Glu Pro Met Ala
Glu Pro Ser Asp
C17H26N4O10 (446.16488560000005)
Glu Pro Val Cys
Glu Gln Gly Asn
Glu Gln Asn Gly
Glu Ser Asp Pro
C17H26N4O10 (446.16488560000005)
Glu Ser Pro Asp
C17H26N4O10 (446.16488560000005)
Glu Val Cys Pro
Glu Val Pro Cys
Gly Asp Gln Gln
Gly Glu Asn Gln
Gly Glu Gln Asn
Gly Asn Glu Gln
Gly Asn Gln Glu
Gly Gln Asp Gln
Gly Gln Glu Asn
Gly Gln Asn Glu
Gly Gln Gln Asp
His Cys Ser Thr
C16H26N6O7S (446.15836060000004)
His Cys Thr Ser
C16H26N6O7S (446.15836060000004)
His Ser Cys Thr
C16H26N6O7S (446.15836060000004)
His Ser Thr Cys
C16H26N6O7S (446.15836060000004)
His Thr Cys Ser
C16H26N6O7S (446.15836060000004)
His Thr Ser Cys
C16H26N6O7S (446.15836060000004)
Ile Cys Asp Pro
Ile Cys Pro Asp
Ile Asp Cys Pro
Ile Asp Pro Cys
Ile Pro Cys Asp
Ile Pro Asp Cys
Leu Cys Asp Pro
Leu Cys Pro Asp
Leu Asp Cys Pro
Leu Asp Pro Cys
Leu Pro Cys Asp
Leu Pro Asp Cys
Met Ala Glu Pro
Met Ala Pro Glu
Met Cys Pro Pro
Met Glu Ala Pro
Met Glu Pro Ala
Met Pro Ala Glu
Met Pro Cys Pro
Met Pro Glu Ala
Met Pro Pro Cys
Asn Ala Asp Gln
Asn Ala Glu Asn
Asn Ala Asn Glu
Asn Ala Gln Asp
Asn Cys Asn Pro
C16H26N6O7S (446.15836060000004)
Asn Cys Pro Asn
C16H26N6O7S (446.15836060000004)
Asn Asp Ala Gln
Asn Asp Gln Ala
Asn Glu Ala Asn
Asn Glu Gly Gln
Asn Glu Asn Ala
Asn Glu Gln Gly
Asn Gly Glu Gln
Asn Gly Gln Glu
Asn Asn Ala Glu
Asn Asn Cys Pro
C16H26N6O7S (446.15836060000004)
Asn Asn Glu Ala
Asn Asn Pro Cys
C16H26N6O7S (446.15836060000004)
Asn Pro Cys Asn
C16H26N6O7S (446.15836060000004)
Asn Pro Asn Cys
C16H26N6O7S (446.15836060000004)
Asn Gln Ala Asp
Asn Gln Asp Ala
Asn Gln Glu Gly
Asn Gln Gly Glu
Pro Ala Glu Met
Pro Ala Met Glu
Pro Cys Asp Ile
Pro Cys Asp Leu
Pro Cys Glu Val
Pro Cys Ile Asp
Pro Cys Leu Asp
Pro Cys Met Pro
Pro Cys Asn Asn
C16H26N6O7S (446.15836060000004)
Pro Cys Pro Met
Pro Cys Val Glu
Pro Asp Cys Ile
Pro Asp Cys Leu
Pro Asp Asp Thr
C17H26N4O10 (446.16488560000005)
Pro Asp Glu Ser
C17H26N4O10 (446.16488560000005)
Pro Asp Ile Cys
Pro Asp Leu Cys
Pro Asp Ser Glu
C17H26N4O10 (446.16488560000005)
Pro Asp Thr Asp
C17H26N4O10 (446.16488560000005)
Pro Glu Ala Met
Pro Glu Cys Val
Pro Glu Asp Ser
C17H26N4O10 (446.16488560000005)
Pro Glu Met Ala
Pro Glu Ser Asp
C17H26N4O10 (446.16488560000005)
Pro Glu Val Cys
Pro Ile Cys Asp
Pro Ile Asp Cys
Pro Leu Cys Asp
Pro Leu Asp Cys
Pro Met Ala Glu
Pro Met Cys Pro
Pro Met Glu Ala
Pro Met Pro Cys
Pro Asn Cys Asn
C16H26N6O7S (446.15836060000004)
Pro Asn Asn Cys
C16H26N6O7S (446.15836060000004)
Pro Pro Cys Met
Pro Pro Met Cys
Pro Ser Asp Glu
C17H26N4O10 (446.16488560000005)
Pro Ser Glu Asp
C17H26N4O10 (446.16488560000005)
Pro Thr Asp Asp
C17H26N4O10 (446.16488560000005)
Pro Val Cys Glu
Pro Val Glu Cys
Gln Ala Asp Asn
Gln Ala Asn Asp
Gln Asp Ala Asn
Gln Asp Gly Gln
Gln Asp Asn Ala
Gln Asp Gln Gly
Gln Glu Gly Asn
Gln Glu Asn Gly
Gln Gly Asp Gln
Gln Gly Glu Asn
Gln Gly Asn Glu
Gln Gly Gln Asp
Gln Asn Ala Asp
Gln Asn Asp Ala
Gln Asn Glu Gly
Gln Asn Gly Glu
Gln Gln Asp Gly
Gln Gln Gly Asp
Ser Cys His Thr
C16H26N6O7S (446.15836060000004)
Ser Cys Thr His
C16H26N6O7S (446.15836060000004)
Ser Asp Glu Pro
C17H26N4O10 (446.16488560000005)
Ser Asp Pro Glu
C17H26N4O10 (446.16488560000005)
Ser Glu Asp Pro
C17H26N4O10 (446.16488560000005)
Ser Glu Pro Asp
C17H26N4O10 (446.16488560000005)
Ser His Cys Thr
C16H26N6O7S (446.15836060000004)
Ser His Thr Cys
C16H26N6O7S (446.15836060000004)
Ser Pro Asp Glu
C17H26N4O10 (446.16488560000005)
Ser Pro Glu Asp
C17H26N4O10 (446.16488560000005)
Ser Thr Cys His
C16H26N6O7S (446.15836060000004)
Ser Thr His Cys
C16H26N6O7S (446.15836060000004)
Thr Cys His Ser
C16H26N6O7S (446.15836060000004)
Thr Cys Ser His
C16H26N6O7S (446.15836060000004)
Thr Asp Asp Pro
C17H26N4O10 (446.16488560000005)
Thr Asp Pro Asp
C17H26N4O10 (446.16488560000005)
Thr His Cys Ser
C16H26N6O7S (446.15836060000004)
Thr His Ser Cys
C16H26N6O7S (446.15836060000004)
Thr Pro Asp Asp
C17H26N4O10 (446.16488560000005)
Thr Ser Cys His
C16H26N6O7S (446.15836060000004)
Thr Ser His Cys
C16H26N6O7S (446.15836060000004)
Val Cys Glu Pro
Val Cys Pro Glu
Val Glu Cys Pro
Val Glu Pro Cys
Val Pro Cys Glu
Val Pro Glu Cys
Gefitinib
C22H24ClFN4O3 (446.15208759999996)
L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors > L01EB - Epidermal growth factor receptor (egfr) tyrosine kinase inhibitors C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163952 - EGFR-targeting Agent C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors D000970 - Antineoplastic Agents
Osmanthuside A
Crosatoside B
A glycosylglucose derivative that is alpha-L-rhamnopyranosyl-(1->2)-beta-D-glucopyranose in which the anomeric hydroxy hydrogen has been replaced by a 2-(4-hydroxyphenyl)ethyl group.
Ethyl 18-bromo-8E,17E19Z-tricosatrien-4,6-diynoate
2-(4-Methoxyphenyl)ethyl 6-O-?-L-arabinopyranosyl-?-D-glucopyranoside
Ethyl 18-bromo-8E,17E,19Z-tricosatrien-4,6-diynoate
3-[[4-[benzylethylamino]phenyl]azo]-1,2-dimethyl-1H-1,2,4-triazolium methyl sulphate
C20H26N6O4S (446.17361560000006)
2-[4-(4-Chlorobenzoyl)phenoxy]-2-methylpropanoic acid 1,1-dimethyl-2-(1-methylethoxy)-2-oxoethyl ester
C24H27ClO6 (446.14960720000005)
ethyl 1-(2,4-difluorophenyl)-6-fluoro-7-(3-methylpiperazin-1-yl)-4-oxo-1,8-naphthyridine-3-carboxylate
C22H21F3N4O3 (446.15656720000004)
ethyl 1-(2,4-difluorophenyl)-6-fluoro-7-(4-methylpiperazin-1-yl)-4-oxo-1,8-naphthyridine-3-carboxylate
C22H21F3N4O3 (446.15656720000004)
3-ETHYL-5-[(E,2E)-1-PHENYL-4-(1,3,3-TRIMETHYL-1,3-DIHYDRO-2H-INDOL-2-YLIDENE)-2-BUTENYLIDENE]-2-THIOXO-1,3-THIAZOLIDIN-4-ONE
Fmoc-L-Homoarginine Hydrochloride Salt
C22H27ClN4O4 (446.17207320000006)
Cloprostenol Sodium
C22H28ClNaO6 (446.14720180000006)
D012102 - Reproductive Control Agents > D003270 - Contraceptive Agents D012102 - Reproductive Control Agents > D008186 - Luteolytic Agents
Cvt-6883
GS-6201 (CVT-6883) is a selective adenosine A2B receptor antagonist. GS-6201 displays high affinity and selectivity for the human adenosine A2B receptors (Ki=22 nM)[1]. GS-6201 reduces caspase-1 activity in the heart, and attenuates cardiac remodeling after acute myocardial infarction (AMI) in the mouse[2]. GS-62013 attenuates the airway reactivity induced by NECA, AMP, or allergen in sensitized mice[3].
GW791343
GW791343 dihydrochloride is a potent human P2X7 receptor negative allosteric modulator (exhibits species-specific activity), produces a non-competitive antagonist effect on human P2X7 receptor, with a pIC50 of 6.9-7.2. GW791343 dihydrochloride can enhance ATP rhythm. GW791343 dihydrochloride can be used in study of neurological disease[1][2].
(3R,3aS,4S,4aS,7R,9aR)-3-Methyl-7-nitro-1-oxo-N,N-diphenyl-1,3,3a,4,4a,5,6,7,8,9a-decahydronaphtho[2,3-c]furan-4-carboxamide
C26H26N2O5 (446.18416260000004)
3-Deschloro-4-Desfluoro-4-Chloro-3-Fluoro Gefitinib
C22H24ClFN4O3 (446.15208759999996)
POLYPHENYL ETHER (5 RINGS) OS-124, STAT. PHASE FOR GC
(2E)-(R)-5-(diphenylamino)-5-oxopent-3-en-2-y13-(5-nitrocyclohex-1-en-1-y1)acylate
C26H26N2O5 (446.18416260000004)
(1s,2r)-2-{[(1s)-1-[(1,3-Dioxo-1,3-Dihydro-2h-Isoindol-2-Yl)methyl]-3,4-Dihydroisoquinolin-2(1h)-Yl]carbonyl}cyclohexanecarboxylic Acid
C26H26N2O5 (446.18416260000004)
N-(Deoxyguanosin-8-yl)-2-aminofluorene
D009676 - Noxae > D002273 - Carcinogens
3-benzyl-4-methyl-7-[(3,4,5-trimethoxybenzyl)oxy]-2H-chromen-2-one
(2S,4R)-1-Acetyl-N-[(1S)-4-[(aminoiminomethyl)amino]-1-(2-benzothiazolylcarbonyl)butyl]-4-hydroxy-2-pyrrolidinecarboxamide
C20H26N6O4S (446.17361560000006)
methyl 4-[5-[(1,3-dioxoisoindol-2-yl)methyl]uran-2-yl]-2-methyl-5-oxo-4,6,7,8-tetrahydro-1H-quinoline-3-carboxylate
2-[2-(4-Methoxyphenyl)ethoxy]-6-[(3,4,5-trihydroxyoxan-2-yl)oxymethyl]oxane-3,4,5-triol
(2S)-2-[[4-[[(6S)-2,4-dioxo-5,6,7,8-tetrahydro-1H-pteridin-6-yl]methylamino]benzoyl]amino]pentanedioic acid
2-(4-methoxyphenyl)ethyl 6-O-a-L-arabinopyranosyl-b-D-glucopyranoside
(1R,2S)-2-[[(1S)-1-[(1,3-dioxo-2-isoindolyl)methyl]-3,4-dihydro-1H-isoquinolin-2-yl]-oxomethyl]-1-cyclohexanecarboxylic acid
C26H26N2O5 (446.18416260000004)
1-(4-amino-1,2,5-oxadiazol-3-yl)-N-[(E)-(3-phenylmethoxyphenyl)methylideneamino]-5-propan-2-yltriazole-4-carboxamide
4-[2-Nitro-5-[4-(phenylmethyl)sulfonyl-1-piperazinyl]phenyl]morpholine
C21H26N4O5S (446.16238260000006)
2-[3-(3,4-Dimethoxyphenyl)-2,4-dioxo-1-quinazolinyl]acetic acid (phenylmethyl) ester
N-[2-(cyclohexylthio)ethyl]-4-methyl-3-[(4-methylphenyl)sulfamoyl]benzamide
1-[3-[(E)-2-cyano-3-(furan-2-ylmethylamino)-3-oxoprop-1-enyl]-4-oxopyrido[1,2-a]pyrimidin-2-yl]piperidine-4-carboxamide
N-[5-[2-(2,5-dimethoxyanilino)-4-thiazolyl]-4-methyl-2-thiazolyl]-2-methylpentanamide
(1S,5R)-3-{[(6-oxo-7,8,9,10-tetrahydro-6H-benzo[c]chromen-3-yl)oxy]acetyl}-1,2,3,4,5,6-hexahydro-8H-1,5-methanopyrido[1,2-a][1,5]diazocin-8-one
C26H26N2O5 (446.18416260000004)
1-(4-amino-1,2,5-oxadiazol-3-yl)-5-(1,3-benzodioxol-5-yl)-N-[(1E)-1-(4-methylphenyl)ethylidene]-1H-1,2,3-triazole-4-carbohydrazide
2-[[2-(5-chloro-2-methoxyanilino)-2-oxoethyl]-methylamino]-N-[2-(4-morpholinyl)phenyl]acetamide
C22H27ClN4O4 (446.17207320000006)
N-[2-[(2S,5R,6S)-5-[[(4-chloroanilino)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]ethyl]-2-(2-pyridinyl)acetamide
C22H27ClN4O4 (446.17207320000006)
N-[2-[(2R,5S,6R)-5-[[(4-chloroanilino)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]ethyl]-2-(2-pyridinyl)acetamide
C22H27ClN4O4 (446.17207320000006)
N-[2-[(2S,5S,6S)-5-[[(4-chloroanilino)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]ethyl]-2-(2-pyridinyl)acetamide
C22H27ClN4O4 (446.17207320000006)
N-[2-[(2S,5S,6R)-5-[[(4-chloroanilino)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]ethyl]-2-(2-pyridinyl)acetamide
C22H27ClN4O4 (446.17207320000006)
N-[2-[(2S,5R,6R)-5-[(4-chlorophenyl)carbamoylamino]-6-(hydroxymethyl)oxan-2-yl]ethyl]-2-pyridin-2-ylacetamide
C22H27ClN4O4 (446.17207320000006)
[(1S,2aR,8bR)-1-(hydroxymethyl)-4-[(3-methoxyphenyl)-oxomethyl]-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-2-yl]-(4-fluorophenyl)methanone
[(1R,2aR,8bR)-1-(hydroxymethyl)-4-[(3-methoxyphenyl)-oxomethyl]-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-2-yl]-(4-fluorophenyl)methanone
N-[2-[(2R,5R,6R)-5-[(4-chlorophenyl)carbamoylamino]-6-(hydroxymethyl)oxan-2-yl]ethyl]-2-pyridin-2-ylacetamide
C22H27ClN4O4 (446.17207320000006)
(2R)-2-[(4S,5S)-8-[2-(2-fluorophenyl)ethynyl]-4-methyl-5-(methylaminomethyl)-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
C23H27FN2O4S (446.16754740000005)
(2S)-2-[(4R,5R)-8-[2-(2-fluorophenyl)ethynyl]-4-methyl-5-(methylaminomethyl)-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
C23H27FN2O4S (446.16754740000005)
N-[2-[(2R,5R,6S)-5-[[(4-chloroanilino)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]ethyl]-2-(2-pyridinyl)acetamide
C22H27ClN4O4 (446.17207320000006)
2-[(1S,3S,4aS,9aR)-6-(benzenesulfonamido)-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N,N-dimethylacetamide
C22H26N2O6S (446.15114960000005)
2-[(1S,3R,4aS,9aR)-6-(benzenesulfonamido)-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N,N-dimethylacetamide
C22H26N2O6S (446.15114960000005)
2-[(1S,3S,4aR,9aS)-6-(benzenesulfonamido)-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N,N-dimethylacetamide
C22H26N2O6S (446.15114960000005)
(1S,2aS,8bS)-N-(3-fluorophenyl)-1-(hydroxymethyl)-2-[1-oxo-2-(2-pyridinyl)ethyl]-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-4-carboxamide
C25H23FN4O3 (446.17540999999994)
(1R,2aR,8bR)-N-(2-fluorophenyl)-1-(hydroxymethyl)-2-[1-oxo-2-(3-pyridinyl)ethyl]-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-4-carboxamide
C25H23FN4O3 (446.17540999999994)
(1S,2aS,8bS)-N-(2-fluorophenyl)-1-(hydroxymethyl)-2-[1-oxo-2-(3-pyridinyl)ethyl]-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-4-carboxamide
C25H23FN4O3 (446.17540999999994)
[(1R,2aS,8bS)-1-(hydroxymethyl)-4-[(3-methoxyphenyl)-oxomethyl]-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-2-yl]-(4-fluorophenyl)methanone
[(1S,2aS,8bS)-1-(hydroxymethyl)-4-[(3-methoxyphenyl)-oxomethyl]-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-2-yl]-(4-fluorophenyl)methanone
(6R,7S,8R)-4-[1,3-benzodioxol-5-yl(oxo)methyl]-8-(hydroxymethyl)-7-[4-(3-methylbut-1-ynyl)phenyl]-1,4-diazabicyclo[4.2.0]octan-2-one
C26H26N2O5 (446.18416260000004)
(6S,7R,8S)-4-[1,3-benzodioxol-5-yl(oxo)methyl]-8-(hydroxymethyl)-7-[4-(3-methylbut-1-ynyl)phenyl]-1,4-diazabicyclo[4.2.0]octan-2-one
C26H26N2O5 (446.18416260000004)
(6S,7S,8S)-4-[1,3-benzodioxol-5-yl(oxo)methyl]-8-(hydroxymethyl)-7-[4-(3-methylbut-1-ynyl)phenyl]-1,4-diazabicyclo[4.2.0]octan-2-one
C26H26N2O5 (446.18416260000004)
(6R,7S,8S)-N-(2-fluorophenyl)-8-(hydroxymethyl)-2-oxo-7-[4-(3-pyridinyl)phenyl]-1,4-diazabicyclo[4.2.0]octane-4-carboxamide
C25H23FN4O3 (446.17540999999994)
(6R,7R,8S)-N-(2-fluorophenyl)-8-(hydroxymethyl)-2-oxo-7-[4-(3-pyridinyl)phenyl]-1,4-diazabicyclo[4.2.0]octane-4-carboxamide
C25H23FN4O3 (446.17540999999994)
(2R)-2-[(4R,5R)-8-[2-(2-fluorophenyl)ethynyl]-4-methyl-5-(methylaminomethyl)-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
C23H27FN2O4S (446.16754740000005)
(2S)-2-[(4S,5S)-8-[2-(2-fluorophenyl)ethynyl]-4-methyl-5-(methylaminomethyl)-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
C23H27FN2O4S (446.16754740000005)
N-[2-[(2R,5S,6S)-5-[[(4-chloroanilino)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]ethyl]-2-(2-pyridinyl)acetamide
C22H27ClN4O4 (446.17207320000006)
2-[(1R,3R,4aR,9aS)-6-(benzenesulfonamido)-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N,N-dimethylacetamide
C22H26N2O6S (446.15114960000005)
2-[(1R,3S,4aR,9aS)-6-(benzenesulfonamido)-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N,N-dimethylacetamide
C22H26N2O6S (446.15114960000005)
2-[(1R,3R,4aS,9aR)-6-(benzenesulfonamido)-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N,N-dimethylacetamide
C22H26N2O6S (446.15114960000005)
2-[(1R,3S,4aS,9aR)-6-(benzenesulfonamido)-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N,N-dimethylacetamide
C22H26N2O6S (446.15114960000005)
2-[(1S,3R,4aR,9aS)-6-(benzenesulfonamido)-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N,N-dimethylacetamide
C22H26N2O6S (446.15114960000005)
(1S,2aR,8bR)-N-(3-fluorophenyl)-1-(hydroxymethyl)-2-[1-oxo-2-(2-pyridinyl)ethyl]-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-4-carboxamide
C25H23FN4O3 (446.17540999999994)
(1R,2aR,8bR)-N-(3-fluorophenyl)-1-(hydroxymethyl)-2-[1-oxo-2-(2-pyridinyl)ethyl]-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-4-carboxamide
C25H23FN4O3 (446.17540999999994)
(1R,2aS,8bS)-N-(3-fluorophenyl)-1-(hydroxymethyl)-2-[1-oxo-2-(2-pyridinyl)ethyl]-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-4-carboxamide
C25H23FN4O3 (446.17540999999994)
(1R,2aS,8bS)-N-(2-fluorophenyl)-1-(hydroxymethyl)-2-[1-oxo-2-(3-pyridinyl)ethyl]-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-4-carboxamide
C25H23FN4O3 (446.17540999999994)
(1S,2aR,8bR)-N-(2-fluorophenyl)-1-(hydroxymethyl)-2-[1-oxo-2-(3-pyridinyl)ethyl]-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-4-carboxamide
C25H23FN4O3 (446.17540999999994)
(6R,7S,8S)-4-[1,3-benzodioxol-5-yl(oxo)methyl]-8-(hydroxymethyl)-7-[4-(3-methylbut-1-ynyl)phenyl]-1,4-diazabicyclo[4.2.0]octan-2-one
C26H26N2O5 (446.18416260000004)
(6R,7R,8R)-4-[1,3-benzodioxol-5-yl(oxo)methyl]-8-(hydroxymethyl)-7-[4-(3-methylbut-1-ynyl)phenyl]-1,4-diazabicyclo[4.2.0]octan-2-one
C26H26N2O5 (446.18416260000004)
(6R,7R,8S)-4-[1,3-benzodioxol-5-yl(oxo)methyl]-8-(hydroxymethyl)-7-[4-(3-methylbut-1-ynyl)phenyl]-1,4-diazabicyclo[4.2.0]octan-2-one
C26H26N2O5 (446.18416260000004)
(6S,7S,8R)-4-[1,3-benzodioxol-5-yl(oxo)methyl]-8-(hydroxymethyl)-7-[4-(3-methylbut-1-ynyl)phenyl]-1,4-diazabicyclo[4.2.0]octan-2-one
C26H26N2O5 (446.18416260000004)
(6S,7R,8R)-4-[1,3-benzodioxol-5-yl(oxo)methyl]-8-(hydroxymethyl)-7-[4-(3-methylbut-1-ynyl)phenyl]-1,4-diazabicyclo[4.2.0]octan-2-one
C26H26N2O5 (446.18416260000004)
(6R,7S,8R)-N-(2-fluorophenyl)-8-(hydroxymethyl)-2-oxo-7-[4-(3-pyridinyl)phenyl]-1,4-diazabicyclo[4.2.0]octane-4-carboxamide
C25H23FN4O3 (446.17540999999994)
(6S,7S,8S)-N-(2-fluorophenyl)-8-(hydroxymethyl)-2-oxo-7-[4-(3-pyridinyl)phenyl]-1,4-diazabicyclo[4.2.0]octane-4-carboxamide
C25H23FN4O3 (446.17540999999994)
(6S,7S,8R)-N-(2-fluorophenyl)-8-(hydroxymethyl)-2-oxo-7-[4-(3-pyridinyl)phenyl]-1,4-diazabicyclo[4.2.0]octane-4-carboxamide
C25H23FN4O3 (446.17540999999994)
(6R,7R,8R)-N-(2-fluorophenyl)-8-(hydroxymethyl)-2-oxo-7-[4-(3-pyridinyl)phenyl]-1,4-diazabicyclo[4.2.0]octane-4-carboxamide
C25H23FN4O3 (446.17540999999994)
(6S,7R,8R)-N-(2-fluorophenyl)-8-(hydroxymethyl)-2-oxo-7-[4-(3-pyridinyl)phenyl]-1,4-diazabicyclo[4.2.0]octane-4-carboxamide
C25H23FN4O3 (446.17540999999994)
7,8-dimethoxy-2-phenyl-5-[(2S,4S,5R)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy-2,3-dihydrochromen-4-one
methyl (3R)-2-{[(4-methyl-2-oxo-2H-chromen-7-yl)oxy]acetyl}-2,3,4,9-tetrahydro-1H-beta-carboline-3-carboxylate
[2-Hydroxy-3-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxypropyl] heptanoate
OGT-IN-2
C23H27ClN2O3S (446.1430822000001)
OGT-IN-2 (compound 4) is a potent O-GlcNAc transferase (OGT) inhibitor, with IC50 values of 30 and 53 μM for sOGT and ncOGT, respectively[1].
1-[2-({5-amino-1-[(1-carboxylato-2-hydroxyethyl)-c-hydroxycarbonimidoyl]pentyl}-c-hydroxycarbonimidoyl)-3,4-dihydroxyphenyl]-1λ⁵-pyridin-1-ylium
(2r,3r,4s)-2,3,10,10-tetramethyl-6-oxo-8-phenyl-3,4-dihydro-2h-1,5,9-trioxatriphenylen-4-yl acetate
(2s,3r,4s,5s,6r)-2-{[(2s,3r,4s,5s,6r)-4,5-dihydroxy-6-(hydroxymethyl)-2-phenoxyoxan-3-yl]oxy}-2-ethyl-6-(hydroxymethyl)oxane-3,4,5-triol
2-methyl-3-oxo-1-(3,4,5-trimethoxyphenyl)butyl 7-methoxy-2h-1,3-benzodioxole-5-carboxylate
2-[(4-methoxyphenyl)methoxy]-6-{[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]methyl}oxane-3,4,5-triol
(2s,3s,4r,5r,6s)-2-[(4-methoxyphenyl)methoxy]-6-({[(2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}methyl)oxane-3,4,5-triol
5-butoxy-7-(hydroxymethyl)-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,5h,7ah-cyclopenta[c]pyran-4-carboxylic acid
ethyl (8e,17e,19e)-18-bromotricosa-8,17,19-trien-4,6-diynoate
3-(hydroxymethyl)-4-[(7-methoxy-2h-1,3-benzodioxol-5-yl)(3,4,5-trimethoxyphenyl)methyl]oxolan-2-one
[(2r,3s,4s,5r,6s)-6-[(7-acetyl-8-hydroxy-6-methylnaphthalen-1-yl)oxy]-3,4,5-trihydroxyoxan-2-yl]methyl (2e)-but-2-enoate
(2r,3r,4s,5s,6r)-2-{[(2r,3r,4s,5s,6r)-4,5-dihydroxy-6-(hydroxymethyl)-2-(2-phenylethoxy)oxan-3-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
[(2r,3s,4s,5r)-3,4,5-trihydroxy-6-(4-hydroxy-2,3-dimethylphenoxy)oxan-2-yl]methyl (2e)-3-(4-hydroxyphenyl)prop-2-enoate
(9r,10r,11r)-5,11-dihydroxy-3,4,19-trimethoxy-9,10-dimethyl-15,17-dioxatetracyclo[10.7.0.0²,⁷.0¹⁴,¹⁸]nonadeca-1(12),2,4,6,13,18-hexaene-6-carboxylic acid
2-methyl-6-{[3,4,5-trihydroxy-6-(2-hydroxy-2-phenylethoxy)oxan-2-yl]methoxy}oxane-3,4,5-triol
1-(1-hydroxyethyl)-4β-rutinosyloxybenzene
{"Ingredient_id": "HBIN000442","Ingredient_name": "1-(1-hydroxyethyl)-4\u03b2-rutinosyloxybenzene","Alias": "NA","Ingredient_formula": "C20H30O11","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "10105","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
4-hydroxyphenylethyl 4-o-β-d-glucopyranosyl-(1→3)-o-α-l-rhamnopyranoside
{"Ingredient_id": "HBIN010566","Ingredient_name": "4-hydroxyphenylethyl 4-o-\u03b2-d-glucopyranosyl-(1\u21923)-o-\u03b1-l-rhamnopyranoside","Alias": "NA","Ingredient_formula": "C20H30O11","Ingredient_Smile": "CC1C(C(C(C(O1)OC2=CC=C(C=C2)CCO)O)OC3C(C(C(C(O3)CO)O)O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "10619","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
2-[(8r,16s,24r)-1,9,17-triazahexacyclo[14.8.0.0²,⁷.0⁸,¹⁷.0¹⁰,¹⁵.0¹⁸,²³]tetracosa-2,4,6,10,12,14,18,20,22-nonaen-24-ylamino]benzoic acid
(9s,10r)-10-hydroperoxy-3,4,5,19-tetramethoxy-9,10-dimethyl-15,17-dioxatetracyclo[10.7.0.0²,⁷.0¹⁴,¹⁸]nonadeca-1(12),2(7),3,5,13,18-hexaen-11-one
[(2r,3s,4s,5r,6r)-3,4,5-trihydroxy-6-[2-(1-hydroxy-4-oxocyclohexa-2,5-dien-1-yl)ethoxy]oxan-2-yl]methyl (2e)-3-phenylprop-2-enoate
2-{[4,5-dihydroxy-6-(hydroxymethyl)-2-(2-phenylethoxy)oxan-3-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
6,8-dihydroxy-3-[(1z)-2-[8-hydroxy-2-methyl-2-(4-methylpent-3-en-1-yl)chromen-5-yl]ethenyl]isochromen-1-one
(2r,3r,4r)-2,3,10,10-tetramethyl-6-oxo-8-phenyl-3,4-dihydro-2h-1,5,9-trioxatriphenylen-4-yl acetate
(2r,3s,4s,5r,6r)-2-(hydroxymethyl)-6-{[(2r,3s,4s,5r,6r)-3,4,5-trihydroxy-6-(2-phenylethoxy)oxan-2-yl]methoxy}oxane-3,4,5-triol
(2r,3r,4s,5s,6r)-2-[(2-methylphenyl)methoxy]-6-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxane-3,4,5-triol
2-(hydroxymethyl)-6-{[3,4,5-trihydroxy-6-(2-phenylethoxy)oxan-2-yl]methoxy}oxane-3,4,5-triol
(1r,4s,7s,10s,19s)-4-(1h-indol-3-ylmethyl)-9,9-dimethyl-6,15,17-trioxa-3-azapentacyclo[11.5.1.0¹,¹⁰.0²,⁷.0¹⁶,¹⁹]nonadeca-2,12-diene-5,18-dione
C26H26N2O5 (446.18416260000004)
(2s)-5,7-dihydroxy-2-(4-hydroxyphenyl)-6-[(4-hydroxyphenyl)methyl]-8-(3-methylbut-2-en-1-yl)-2,3-dihydro-1-benzopyran-4-one
(2s,3r,4s,5s,6r)-2-{[(3s)-5-chloro-8-hydroxy-7-methyl-3-pentyl-3,4-dihydro-1h-2-benzopyran-6-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
11-ethylidene-7-hydroxy-7,14-dimethyl-2-methylidene-3,12-dioxo-4,13,17-trioxatetracyclo[8.6.1.0¹,⁵.0¹⁰,¹⁴]heptadec-5-en-16-yl 2-(hydroxymethyl)prop-2-enoate
[(2r,3s,4s,5r,6r)-3,4,5-trihydroxy-6-[2-(4-hydroxyphenyl)ethoxy]oxan-2-yl]methyl (2e)-3-(4-hydroxyphenyl)prop-2-enoate
(2e)-3-{4-[2-(4-hydroxyphenyl)ethyl]-2-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl}prop-2-enoic acid
19-ethyl-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.0²,¹¹.0⁴,⁹.0¹⁵,²⁰]henicosa-1(21),2,4,6,8,10,15(20)-heptaen-19-yl hexanoate
C26H26N2O5 (446.18416260000004)
(3s,4s)-3-(hydroxymethyl)-4-[(s)-(7-methoxy-2h-1,3-benzodioxol-5-yl)(3,4,5-trimethoxyphenyl)methyl]oxolan-2-one
(3,8-dihydroxy-6-methoxy-4,5-dimethyl-1-oxo-4h-2-benzopyran-3-yl)methyl 2,4-dihydroxy-3,5,6-trimethylbenzoate
(3s,5r,6s,7s,8r,10r,12s)-5,17-bis(hydroxymethyl)-15-methyl-12-phenyl-2,4,9,13-tetraoxatetracyclo[8.7.1.0³,⁸.0¹⁴,¹⁸]octadeca-1(17),14(18),15-triene-6,7,16-triol
(1s,5e,7r,10r,11z,14r,16s)-11-ethylidene-7-hydroxy-7,14-dimethyl-2-methylidene-3,12-dioxo-4,13,17-trioxatetracyclo[8.6.1.0¹,⁵.0¹⁰,¹⁴]heptadec-5-en-16-yl 2-(hydroxymethyl)prop-2-enoate
(2s,3r,4s,5s,6r)-2-(3,4-dimethylphenoxy)-6-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxane-3,4,5-triol
(3s,4r)-3-[(s)-hydroxy(3,4,5-trimethoxyphenyl)methyl]-4-[(7-methoxy-2h-1,3-benzodioxol-5-yl)methyl]oxolan-2-one
2-[2-(acetyloxy)-4,6-dimethoxy-3-methylbenzoyl]-3,5-dimethoxy-6-methylphenyl acetate
4-(1h-indol-3-ylmethyl)-9,9-dimethyl-6,15,17-trioxa-3-azapentacyclo[11.5.1.0¹,¹⁰.0²,⁷.0¹⁶,¹⁹]nonadeca-2,12-diene-5,18-dione
C26H26N2O5 (446.18416260000004)
(1s,2s,4r,7z,8r,11r)-7-ethylidene-8-hydroxy-4,11-dimethyl-16-methylidene-6,15-dioxo-5,14,17-trioxatetracyclo[9.5.1.0¹,¹³.0⁴,⁸]heptadec-12-en-2-yl 2-(hydroxymethyl)prop-2-enoate
17-ethylidene-4,14-dimethyl-10-methylidene-9,16-dioxo-5,8,15,18-tetraoxapentacyclo[9.6.1.0¹,¹⁴.0⁴,⁶.0⁷,¹¹]octadecan-12-yl 2-(hydroxymethyl)prop-2-enoate
1,10-dihydroxy-2,8,10-trimethyl-6-{[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}anthracen-9-one
methyl 1-(acetyloxy)-3-hydroxy-1-methyl-7-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2,3,3a,6,7,7a-hexahydroindene-4-carboxylate
2-({3,5-dihydroxy-2-[4-(2-hydroxyethyl)phenoxy]-6-methyloxan-4-yl}oxy)-6-(hydroxymethyl)oxane-3,4,5-triol
[(2r,3s,4s,5r,6s)-6-[(7-acetyl-8-hydroxy-6-methylnaphthalen-1-yl)oxy]-3,4,5-trihydroxyoxan-2-yl]methyl but-2-enoate
[(4s)-3,8-dihydroxy-6-methoxy-4,5-dimethyl-1-oxo-4h-2-benzopyran-3-yl]methyl 2,4-dihydroxy-3,5,6-trimethylbenzoate
methyl (1s,2r,4r,10s,12r,14s,15s)-2-(acetyloxy)-12-methyl-17-oxo-4-(prop-1-en-2-yl)-11,16,18,19-tetraoxapentacyclo[12.2.2.1⁶,⁹.0¹,¹⁵.0¹⁰,¹²]nonadeca-6,8-diene-7-carboxylate
7-ethylidene-8-hydroxy-4,11-dimethyl-16-methylidene-6,15-dioxo-5,14,17-trioxatetracyclo[9.5.1.0¹,¹³.0⁴,⁸]heptadec-12-en-2-yl 2-(hydroxymethyl)prop-2-enoate
(2s,3r,4r,5r,6r)-2-methyl-6-{[(2s,3r,4r,5s,6s)-3,4,5-trihydroxy-6-[(2r)-2-hydroxy-2-phenylethoxy]oxan-2-yl]methoxy}oxane-3,4,5-triol
(19s)-19-ethyl-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.0²,¹¹.0⁴,⁹.0¹⁵,²⁰]henicosa-1(21),2,4,6,8,10,15(20)-heptaen-19-yl hexanoate
C26H26N2O5 (446.18416260000004)
(1s,2r)-2-methyl-3-oxo-1-(3,4,5-trimethoxyphenyl)butyl 7-methoxy-2h-1,3-benzodioxole-5-carboxylate
(3ar,4s,6ar,8s,9r,9as,9bs)-8-(acetyloxy)-3,6-dimethylidene-2-oxo-octahydrospiro[azuleno[4,5-b]furan-9,2'-oxiran]-4-yl 2-[(acetyloxy)methyl]prop-2-enoate
3-[hydroxy(3,4,5-trimethoxyphenyl)methyl]-4-[(7-methoxy-2h-1,3-benzodioxol-5-yl)methyl]oxolan-2-one
(2r,3r,4s,5s,6r)-2-[2-(4-methoxyphenyl)ethoxy]-6-({[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}methyl)oxane-3,4,5-triol
8-(acetyloxy)-3,6-dimethylidene-2-oxo-octahydrospiro[azuleno[4,5-b]furan-9,2'-oxiran]-4-yl 2-[(acetyloxy)methyl]prop-2-enoate
(1r,2r)-1-(7-methoxy-2h-1,3-benzodioxol-5-yl)-2-methyl-3-oxobutyl 3,4,5-trimethoxybenzoate
(1r,4r,6r,7r,11s,12s,14r,17e)-17-ethylidene-4,14-dimethyl-10-methylidene-9,16-dioxo-5,8,15,18-tetraoxapentacyclo[9.6.1.0¹,¹⁴.0⁴,⁶.0⁷,¹¹]octadecan-12-yl 2-(hydroxymethyl)prop-2-enoate
5,17-bis(hydroxymethyl)-15-methyl-12-phenyl-2,4,9,13-tetraoxatetracyclo[8.7.1.0³,⁸.0¹⁴,¹⁸]octadeca-1(17),14(18),15-triene-6,7,16-triol
(2r,3r,4s,5s,6r)-2-[2-(4-methoxyphenyl)ethoxy]-6-({[(2s,3r,4s,5s)-3,4,5-trihydroxyoxan-2-yl]oxy}methyl)oxane-3,4,5-triol
(2s,3r,4s,5s,6r)-2-{[(2r,3r,4s,5s,6r)-4,5-dihydroxy-6-(hydroxymethyl)-2-(2-phenylethoxy)oxan-3-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
(3s,5r,6s,7s,8r,10s,12s)-5-(hydroxymethyl)-12-(4-hydroxyphenyl)-15,17-dimethyl-2,4,9,13-tetraoxatetracyclo[8.7.1.0³,⁸.0¹⁴,¹⁸]octadeca-1(17),14(18),15-triene-6,7,16-triol
2-{1,9,17-triazahexacyclo[14.8.0.0²,⁷.0⁸,¹⁷.0¹⁰,¹⁵.0¹⁸,²³]tetracosa-2,4,6,10,12,14,18,20,22-nonaen-24-ylamino}benzoic acid
(3s,4s)-3-(hydroxymethyl)-4-[(7-methoxy-2h-1,3-benzodioxol-5-yl)(3,4,5-trimethoxyphenyl)methyl]oxolan-2-one
2-[2-(4-methoxyphenyl)ethoxy]-6-{[(3,4,5-trihydroxyoxan-2-yl)oxy]methyl}oxane-3,4,5-triol
5-(hydroxymethyl)-12-(4-hydroxyphenyl)-15,17-dimethyl-2,4,9,13-tetraoxatetracyclo[8.7.1.0³,⁸.0¹⁴,¹⁸]octadeca-1(17),14(18),15-triene-6,7,16-triol
methyl 2-{[(2s,3r,4s,5s,6r)-6-({[(2r,3r,4r)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy}methyl)-3,4,5-trihydroxyoxan-2-yl]oxy}benzoate
C19H26O12 (446.14241960000004)
1-(2-hydroxy-4-{[(2s,3s,4r,5s,6s)-3,4,5-trihydroxy-6-({[(2s,3s,4s,5s)-3,4,5-trihydroxyoxan-2-yl]oxy}methyl)oxan-2-yl]oxy}phenyl)ethanone
C19H26O12 (446.14241960000004)
[(2r,3s,4s,5r,6r)-3,4,5-trihydroxy-6-(2-phenylethoxy)oxan-2-yl]methyl (2e)-3-(3,4-dihydroxyphenyl)prop-2-enoate
[(2r,3s,4s,5r,6r)-3,4,5-trihydroxy-6-[2-(4-hydroxyphenyl)ethoxy]oxan-2-yl]methyl 3-(4-hydroxyphenyl)prop-2-enoate
10-hydroxy-8-[5-hydroxy-4-(hydroxymethyl)-1,3-dioxan-2-yl]-7-methoxy-3-methyl-1-propyl-1h-cyclohexa[g]isochromene-6,9-dione
(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl 4-[(3r,4r,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]benzoate
C19H26O12 (446.14241960000004)
methyl (1s,3r,3as,7r,7ar)-1-(acetyloxy)-3-hydroxy-1-methyl-7-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2,3,3a,6,7,7a-hexahydroindene-4-carboxylate
3-{4-[2-(4-hydroxyphenyl)ethyl]-2-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl}prop-2-enoic acid
[(1s,4r,7s,8s,10r,11s)-10-methoxy-2-oxo-8-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3,9-dioxatricyclo[5.3.1.0⁴,¹¹]undec-5-en-6-yl]methyl acetate
C19H26O12 (446.14241960000004)
(3s,5r,6s,7s,8r,10r,12s)-5-(hydroxymethyl)-12-(4-hydroxyphenyl)-15,17-dimethyl-2,4,9,13-tetraoxatetracyclo[8.7.1.0³,⁸.0¹⁴,¹⁸]octadeca-1(17),14(18),15-triene-6,7,16-triol
2-[(5-chloro-8-hydroxy-7-methyl-3-pentyl-3,4-dihydro-1h-2-benzopyran-6-yl)oxy]-6-(hydroxymethyl)oxane-3,4,5-triol
9-{[2,3-dihydroxy-5-(hydroxymethyl)-4-methoxycyclohexyl]oxy}-3-hydroxy-7-methoxy-1-methylbenzo[c]chromen-6-one
(3as,4s,5s,5ar,9as,9br)-5-(acetyloxy)-5a-(methoxycarbonyl)-9-methyl-3-methylidene-2-oxo-3ah,4h,5h,9ah,9bh-naphtho[1,2-b]furan-4-yl (2s,3s)-2,3-dimethyloxirane-2-carboxylate
1-(7-methoxy-2h-1,3-benzodioxol-5-yl)-2-methyl-3-oxobutyl 3,4,5-trimethoxybenzoate
methyl (1s,4as,6s)-7-[(acetyloxy)methyl]-6-hydroxy-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,5h,6h-cyclopenta[c]pyran-4-carboxylate
C19H26O12 (446.14241960000004)
(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl benzoate
C19H26O12 (446.14241960000004)